Sign In
Buy BLFS
$27.25
-0.240 (-0.87%)
At Close: Jun 03, 2026
New Strong Sell Stocks for October 9th
06:01am, Monday, 09'th Oct 2023
BLFS, BWMN and FTEK have been added to the Zacks Rank #5 (Strong Sell) List on October 9, 2023.
New Strong Sell Stocks for September 13th
09:01am, Wednesday, 13'th Sep 2023
BLFS, ALCO and AFCG have been added to the Zacks Rank #5 (Strong Sell) List on September 13, 2023.
BioLife Hit By An Inventory Correction
08:58am, Wednesday, 30'th Aug 2023
BioLife is facing setbacks due to a difficult funding environment, inventory corrections, and a decline in COVID-related revenues. The company's acquisitions have negatively impacted margins and cash
Why Shares of BioLife Solutions Plummeted This Week
04:06pm, Friday, 11'th Aug 2023
BioLife Solutions focuses on cell- and gene-therapy preservation tools, used primarily by the biotech industry. The company did trim its losses, year over year, in the quarter.
Why Shares of BioLife Solutions Are Slumping on Wednesday
01:38pm, Wednesday, 09'th Aug 2023
BioLife Solutions said it is divesting itself of some assets to focus on its higher-margin business. The company saw declining revenue but narrowed its losses dramatically.
BioLife Solutions, Inc. (BLFS) Reports Q2 Loss, Misses Revenue Estimates
07:41pm, Tuesday, 08'th Aug 2023
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $1.71 per share a year ago.
Atrion Corp (ATRI): A Medical Device Stock with Good Outperformance Potential
03:03pm, Tuesday, 08'th Aug 2023
Atrion Corp ( ATRI , Financial), a leading player in the Medical Devices & Instruments industry, is currently trading at $557 per share. The company has a market capitalization of $980.596 million and
EVP & Chief Scientific Officer Aby Mathew Sells 20,000 Shares of BioLife Solutions Inc (BLFS)
02:23pm, Saturday, 27'th May 2023
On May 25, 2023, Aby Mathew, the Executive Vice President and Chief Scientific Officer of BioLife Solutions Inc ( BLFS , Financial), sold 20,000 shares of the company's stock. This recent transaction
EVP & Chief Scientific Officer Aby Mathew Sells 20,000 Shares of BioLife Solutions Inc
02:17pm, Friday, 26'th May 2023
On May 25, 2023, Aby Mathew, the Executive Vice President and Chief Scientific Officer of BioLife Solutions Inc ( BLFS , Financial), sold 20,000 shares of the company's stock. This recent transaction
BioLife Solutions, Inc. (BLFS) Q1 2023 Earnings Call Transcript
09:30pm, Wednesday, 10'th May 2023
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Troy Wichterman - CFO Michael Rice - Chairman & CEO Conference Call Participants Ja
BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Misses Revenue Estimates
06:59pm, Wednesday, 10'th May 2023
BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.17 per share a year ago.
BioLife Solutions: Capitalizing On The Future Of Biopreservation
12:08pm, Tuesday, 28'th Mar 2023
BioLife Solutions, a leading provider of bioproduction tools and services, is poised for growth as the demand for biologics and regenerative medicine increases. CryoStor and HypoThermosol have shown s
BioLife Solutions Is Set To Finally Absorb Its Acquisitions
07:51am, Saturday, 25'th Mar 2023
An acquisition spree has produced a host of problems, costs, write-offs, a collapse in gross margins and profits, cash bleed, and significant dilution. While only the evo and Sexton acquisitions have
BioLife Solutions, Inc. (BLFS) Q4 2022 Earnings Call Transcript
09:55pm, Thursday, 16'th Mar 2023
BioLife Solutions, Inc. (NASDAQ:BLFS ) Q4 2022 Earnings Conference Call March 16, 2023 4:30 PM ET Company Participants Troy Wichterman – Chief Financial Officer Mike Rice – Chairman and Chief Exec
Community Health (CYH) to Divest Two NC Hospitals for $320M
03:12pm, Wednesday, 01'st Mar 2023 Zacks Investment Research
Community Health (CYH) expects the North Carolina hospitals' divestment to close at a later part of this year.
